統聯精密(688210.SH):公司的喂料目前仍以不鏽鋼為主
格隆匯12月14日丨統聯精密(688210.SH)近期在接待機構投資者調研時表示,公司的喂料目前仍以不鏽鋼為主。公司通過持續的投入,目前已在316L、304L 以及17-4PH 三款牌號的喂料上具備了自制能力,且已掌握鈦合金喂料開發技術,相關發明專利“一種鈦合金金屬粉末注射成型喂料及其製備方法”已取得授權。但公司的喂料大部分仍來自於外購,主要系一方面部分特定產品由客户指定喂料品牌,另一方面,基於現有喂料需求規模,喂料自給不具有比較成本優勢所致。此外,針對有特殊性能要求的產品,公司會自研自制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.